Chemoinformaics analysis of Cyclohexane, 1-methyl-4-(1-methylethenyl)-, cis-
Molecular Weight | 138.254 | nRot | 1 |
Heavy Atom Molecular Weight | 120.11 | nRig | 7 |
Exact Molecular Weight | 138.141 | nRing | 1 |
Solubility: LogS | -4.753 | nHRing | 0 |
Solubility: LogP | 4.464 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 28 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 10 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 28.7023 |
nHD | 0 | BPOL | 18.0577 |
QED | 0.487 |
Synth | 2.277 |
Natural Product Likeliness | 0.995 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0.001 |
HIA | 0.003 |
CACO-2 | -4.403 |
MDCK | 0.0000217 |
BBB | 0.994 |
PPB | 0.837174 |
VDSS | 2.283 |
FU | 0.0845503 |
CYP1A2-inh | 0.549 |
CYP1A2-sub | 0.859 |
CYP2c19-inh | 0.317 |
CYP2c19-sub | 0.839 |
CYP2c9-inh | 0.257 |
CYP2c9-sub | 0.869 |
CYP2d6-inh | 0.026 |
CYP2d6-sub | 0.637 |
CYP3a4-inh | 0.039 |
CYP3a4-sub | 0.233 |
CL | 6.644 |
T12 | 0.132 |
hERG | 0.033 |
Ames | 0.016 |
ROA | 0.023 |
SkinSen | 0.296 |
Carcinogencity | 0.235 |
EI | 0.987 |
Respiratory | 0.272 |
NR-Aromatase | 0.006 |
Antiviral | No |
Prediction | 0.948147 |